VAERS reports by lot

Merck HPV lot L037554: VAERS reports

60 VAERS reports list lot L037554 as a Merck HPV vaccine, received between 2016-07-29 and 2018-05-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
60
Reports
12%
Marked serious
0
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2836%
General / Systemic (non-local)1114%
Cardiac / Cardiovascular810%
Injection-site / Local reaction810%
Allergic / Anaphylactic68%
Musculoskeletal68%
Dermatological (non-injection-site)56%
Respiratory23%
Gastrointestinal23%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California12
Washington4
South Carolina3
Virginia3
Kansas2
South Dakota2
Colorado1
Nevada1
Michigan1
Oregon1
Tennessee1
Illinois1

Reports by month received

2016-071
2016-086
2016-0912
2016-102
2016-1113
2016-123
2017-014
2017-022
2017-032
2017-041
2017-051
2017-063
2017-072
2017-083
2017-092
2017-111
2018-011
2018-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.